Dr. Deepak Johnson Speaks on Multidisciplinary Management of Liver Cancer at Oncoinsight Conference

 

Dr. Deepak Johnson Speaks on Multidisciplinary Management of Liver Cancer at Oncoinsight Conference



A Landmark Discussion on Advanced Liver Cancer Care at Parumala Hospital

Liver cancer remains one of the most challenging cancers to treat, requiring a multidisciplinary approach for optimal patient outcomes. At the prestigious Oncoinsight Conference, hosted by Parumala Hospital, renowned medical expert Dr. Deepak Johnson served as faculty for a crucial session on the Multidisciplinary Management of Liver Cancer.

This conference brought together leading oncologists, hepatologists, surgeons, and interventional radiologists to discuss cutting-edge treatments, evolving technologies, and comprehensive care strategies for liver cancer patients.


Why Is Multidisciplinary Management Crucial for Liver Cancer?

Liver cancer, particularly Hepatocellular Carcinoma (HCC) and Cholangiocarcinoma, is complex and requires a team-based approach. Unlike many cancers that have a straightforward treatment plan, liver cancer demands input from multiple specialists, including:

Medical Oncologists – Chemotherapy, targeted therapy, and immunotherapy
Hepatologists – Managing liver function, cirrhosis, and overall liver health
Surgical Oncologists – Liver resection and transplantation
Interventional Radiologists – Minimally invasive procedures like TACE (Transarterial Chemoembolization) and TARE (Transarterial Radioembolization)
Radiation Oncologists – Advanced radiotherapy techniques
Palliative Care Specialists – Improving quality of life for advanced-stage patients

A collaborative, patient-centered approach ensures the best possible treatment strategy is selected for each individual.


Key Insights from Dr. Deepak Johnson’s Session

Dr. Deepak Johnson, an expert in liver oncology and multidisciplinary cancer care, shared critical advancements and best practices for treating liver cancer. Some of the major highlights from his session included:

1️⃣ Importance of Early Diagnosis & Staging

🔹 Liver cancer is often diagnosed late, making treatment more difficult.
🔹 Regular screening in high-risk patients (e.g., those with cirrhosis or hepatitis B/C) improves survival rates.
🔹 Advanced imaging techniques like MRI, CT scans, and PET scans play a key role in accurate staging.

2️⃣ Advances in Targeted Therapy & Immunotherapy

🔹 Molecular profiling of liver tumors allows personalized treatment.
🔹 Targeted therapies like Sorafenib, Lenvatinib, and Cabozantinib are revolutionizing liver cancer treatment.
🔹 Immunotherapy (Checkpoint inhibitors like Nivolumab & Atezolizumab) shows promising results in improving survival.

3️⃣ Role of Interventional Radiology in Liver Cancer

🔹 TACE (Transarterial Chemoembolization) – Direct delivery of chemotherapy to the liver tumor.
🔹 TARE (Transarterial Radioembolization) – Radiation beads target cancer cells while sparing healthy liver tissue.
🔹 Ablative techniques like RFA (Radiofrequency Ablation) and MWA (Microwave Ablation) are minimally invasive alternatives for patients ineligible for surgery.

4️⃣ Liver Transplantation: A Curative Option for Select Patients

🔹 For early-stage liver cancer with cirrhosis, liver transplant can offer a potential cure.
🔹 The Milan and UCSF criteria help identify the best candidates for transplant.
🔹 Advances in living donor liver transplantation (LDLT) have improved access to this life-saving procedure.

5️⃣ Integration of Palliative and Supportive Care

🔹 In advanced-stage liver cancer, palliative care plays a crucial role in symptom management.
🔹 Nutritional support, pain management, and psychological care improve patient well-being.
🔹 Multidisciplinary teams ensure holistic treatment approaches, addressing both medical and quality-of-life concerns.


Oncoinsight Conference: A Hub for Oncology Innovations

The Oncoinsight Conference at Parumala Hospital served as a vital platform for experts to exchange knowledge, discuss research advancements, and explore innovative approaches in cancer care.

This year’s focus on liver cancer management highlighted the importance of teamwork among specialists, with Dr. Deepak Johnson’s session offering a wealth of knowledge and practical insights for healthcare professionals treating liver cancer.

Key Takeaways from the Conference:

Multidisciplinary care leads to better patient outcomes
New therapies & interventional techniques are transforming liver cancer treatment
Early detection remains critical for curative options like surgery & transplantation
Collaboration between medical, surgical, and radiology teams is essential

With experts like Dr. Deepak Johnson leading the way, the future of liver cancer treatment looks promising, offering patients hope for better survival and quality of life.


Final Thoughts

The session by Dr. Deepak Johnson at the Oncoinsight Conference emphasized the need for a multidisciplinary, patient-centered approach in the battle against liver cancer.

With emerging treatment modalities, targeted therapies, and advanced interventional radiology techniques, the medical community is continuously improving outcomes for liver cancer patients. Events like Oncoinsight foster collaboration, learning, and innovation, ultimately shaping the future of oncology care.

🔥 Knowledge is power! The more we learn and implement advanced treatments, the better we can fight liver cancer. 🔥






Comments

Be Connected

NISD Sponsored REGIONAL SEMINAR ON AGING 2024

Diabetes Reversal: Myth or Reality? 🤔 Quest

BREATHE – Transforming Pulmonary Care

Proud Achievement: Our College Recognized as a Top 10 Promising Medical College

📚🌟 Spreading the Love for Reading: ATHENEUM Book Collection Campaign 🌟📚

Embracing Generosity: Bringing Joy to the Inmates of the Old Age Home

Bringing Hope and Healing: Celebrating the Expertise of our ENT Doctors at Medical College Hospital

Title: Breaking News: National Training Program on Pharmacovigilance to Enhance Drug Safety Introduction: In a significant development, the ADR Monitoring Centre of the Department of Pharmacology at BCMCH (Benedictine College of Medicine and Health Sciences) is conducting a National Training Program under the aegis of the Pharmaco Vigilance Program of India (PVPI). This program aims to educate and empower healthcare professionals to enhance drug safety through effective pharmacovigilance practices. With esteemed speakers and participants from across the country, this training program promises to be a transformative event for the field of pharmacology. Program Details: The National Training Program is scheduled for Friday, the 3rd of May, commencing at 7 PM. The program will feature distinguished speakers who are experts in the field of pharmacovigilance, including Dr. Shwetha Reba Mathews and Dr. Suman Varghese Sam. Dr. Mathews, who was recently appointed as one of the National Pharmacovigilance trainers, brings a wealth of experience and knowledge to the event. Dr. Sam, a renowned psychiatrist, will also be sharing valuable insights on drug safety from a mental health perspective. The program will be moderated by Dr. Jacob Jesurun, the Coordinator of the ADR Monitoring Centre. Importance of Pharmacovigilance: Pharmacovigilance plays a crucial role in ensuring the safety and well-being of patients. It involves the monitoring, detection, assessment, and prevention of adverse drug reactions (ADRs). By systematically collecting and analyzing data on drug safety, healthcare professionals can identify potential risks associated with medications and take appropriate measures to minimize harm. The National Training Program aims to foster a culture of pharmacovigilance across the country, ultimately leading to improved patient outcomes. Impact on Patient Safety: The primary objective of this training program is to equip healthcare professionals with the necessary skills and knowledge to identify and report adverse drug reactions effectively. By raising awareness about the importance of pharmacovigilance, the program seeks to enhance patient safety. Participants attending the program will gain a deeper understanding of the significance of adverse drug reaction monitoring and reporting, enabling them to contribute to a safer healthcare environment. National Reach: The National Training Program has attracted participants from all corners of the country. This diverse group of healthcare professionals represents various fields, including pharmacology, medicine, nursing, and pharmacy. The program's national scope reflects the growing recognition of the importance of pharmacovigilance in India and the commitment of healthcare professionals to ensuring the safe use of medications. Conclusion: As the National Training Program on Pharmacovigilance approaches, the Department of Pharmacology at BCMCH is poised to deliver an impactful and meaningful session. With esteemed speakers, expert moderation, and participants from across the country, this program promises to be a transformative event in the field of drug safety. By equipping healthcare professionals with the necessary knowledge and skills, the program aims to improve patient outcomes and contribute to a safer and more informed healthcare system. The efforts of the department and the participants in attending this training program are commendable, and their commitment to drug safety is an inspiration for the entire medical community.

BCMCH E-Cell Shines in IIT Bombay's Top 50!